Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To investigate efficacy, safety and PK of gemcitabine and paclitaxel combination in patients
with metastatic breast cancer after adjuvant/neo-adjuvant chemotherapy with anthracycline
regimen